Lakewood-Amedex

Infectious Diseases: The Challenge of the 21st Century

Home

Company Overview

Management

Board of Directors

Products & Pipeline

Nubiotics

HUS Program

nRNA Technology

News & Publications

Press Releases

Related News Articles

Intellectual Property

Investor Relations

Investor News

Contact Us

Products & Pipeline

Lakewood-Amedex has a unique portfolio of anti-infective products including:

 

¨      a novel family of anti-bacterial small molecules, NuBiotics, shown to be bactericidal against 70 different strains of antibiotic-resistant pathogens in vitro

¨      a fully humanized monoclonal antibody product exclusively licensed from Tufts University, targeted at enteric shiga toxin producing pathogens that cause severe often fatal food poisoning.

¨      a proprietary nanoRNA technology for treating viral disease by blocking viral replication in the host organism at the genetic level.